Elicio Therapeutics Analyst Ratings
Elicio Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Elicio Therapeutics, Maintains $10 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS) and Elicio Therapeutics (ELTX)
Elicio Therapeutics Analyst Ratings
Elicio Therapeutics Analyst Ratings
Elicio Therapeutics Analyst Ratings
Buy Rating Upheld for Elicio Therapeutics Amid Solid Financial Position and Promising Clinical Results
Elicio Therapeutics Analyst Ratings
H.C. Wainwright Reiterates Their Hold Rating on Angion Biomedica (ANGN)
Angion Biomedica Cut to Neutral From Buy by HC Wainwright & Co.
Angion Biomedica analyst ratings
Oppenheimer Downgrades Angion Biomedica to Perform From Outperform, Removes $8 Price Target
Angion Biomedica Cut to Perform From Outperform by Oppenheimer
Angion Biomedica Price Target Cut to $1.50/Share From $5.00 by Stifel
Angion Biomedica Cut to Hold From Buy by Stifel
Angion Biomedica analyst ratings
Stifel Downgrades Angion Biomedica to Hold, Lowers Price Target to $1.5
No Data